linaclotide

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 851199-59-2

Where It Comes From

9 FDA-registered drug labelers
Allergan, Inc.
Aurobindo Pharma Limited
Chengdu Shengnuo Biopharm Co. Ltd.
Corden Pharma Colorado, Inc.
Hangzhou XinHan Biopharma Co., Ltd.
Hybio Pharmaceutical Co. Ltd
MSN Life Sciences Private Limited
Polypeptide Laboratories Inc
SUN PHARMACEUTICAL INDUSTRIES, INC.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • Linzess
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS851199-59-2
PubChem CID16158208
DTXSIDDTXSID90234256
FormulaC59H79N15O21S6
Mol. Weight1526.8 g/mol
SMILESCC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O

Data Sources

161582082026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/linaclotide/cids/JSON

Archive: data/sources/pubchem_name/linaclotide.json

CAS 851199-59-22026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json